Almost Half of Coronavirus Sufferers Report Depression

Summary: Almost 50% of people diagnosed with coronavirus report symptoms of depression following their diagnosis.

Source: Anglia Ruskin University

Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health.

Researchers from Bangladesh, the United States and Anglia Ruskin University (ARU) in the UK carried out a cross-sectional survey of more than 1,000 Bangladeshi adult coronavirus patients over the course of one month.

A total of 48% of respondents were categorized as having moderate to severe depression, with a higher prevalence in those with persistent symptoms, low family income and poor health status.

This shows a depressed looking man
Almost half of people testing positive for coronavirus have reported symptoms of depression. Image is in the public domain

A fifth of those surveyed reported having persistent COVID-19 symptoms, the most common of these being diarrhea and fatigue. Around a quarter of patients had attempted to self-medicate their symptoms with over-the-counter medicines, rather than contact health services.

Co-author Professor Shahina Pardhan, Director of Anglia Ruskin University’s Vision and Eye Research Institute, said: “Our study found a high number of respondents suffering depression alongside their COVID-19 symptoms, particularly those who were more vulnerable. We know that the World Health Organisation has reported that mental health services across the world have been disrupted by the pandemic, and this study shows the pressing need for these services among those testing positive for the virus.”

About this COVID-19 and depression research news

Source: Anglia Ruskin University
Contact: Press Office – Anglia Ruskin University
Image: The image is in the public domain

Original Research: Open access.
Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh” by Md. Saiful Islam et al. International Journal of Environmental Research and Public Health


Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh

Background: Coronavirus disease (COVID-19) has affected people’s lives globally. While important research has been conducted, much remains to be known. In Bangladesh, initial treatment (self-administered, hospitalized), persistent COVID-19 symptoms (“long COVID-19”), and whether COVID-19 leads to changes in mental state, such as depressive symptoms, of people are not known. This study aimed to examine treatment, persistent symptoms, and depression in people who had been infected with COVID-19 in Bangladesh. 

Methods: A cross-sectional survey was conducted on 1002 individuals infected with COVID-19 (60% male; mean age = 34.7 ± 13.9; age range = 18–81 years), with data taken over a one-month period (11 September 2020 to 13 October 2020). A self-reported online questionnaire was used to collect data on socio-demographics, lifestyle, COVID-19 symptoms (during and beyond COVID-19), medication (over-the-counter or doctor-prescribed), and depression (assessed using the Patient Health Questionnaire (PHQ-9)). 

Results: Twenty-four percent of participants self-medicated with over-the-counter medicine when they were first diagnosed with COVID-19. Self-medication was higher among female vs. male respondents (29.6% vs. 20.2%, respectively, p = 0.002). A minority (20%) reported that they experienced persistent COVID-like symptoms after recovering from COVID-19. The most reported persistent symptoms were diarrhea (12.7%) and fatigue (11.5%). Forty-eight percent of participants were categorized as having moderate to severe depression. Based on multivariate regression analysis, depression during COVID-19 was positively associated with lower family income, poor health status, sleep disturbance, lack of physical activity, hypertension, asthma/respiratory problems, fear of COVID-19 re-infection, and persistent COVID-19 symptoms. 

Conclusions: The findings suggest a need for appropriate interventions for COVID-19 patients to promote physical and mental wellbeing.

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
  1. In the DSM-5 there is a diagnosis of F06.31 (293.83) Depressive Disorder due to medical condition. This diagnosis is found with people with COPD, different types of Cancer, Heart Disorders, Lung Disease, Lupus etc. There is also diagnosis of F06.3 (293.64)Anxiety due Medical Condition.

  2. My daughter has covid and the navy only gave her 10 ten days to recover .
    Tell this to the military.

  3. Not buying this for a minute. First off, many people are told they have the virus when the PCR testing is 100% faulty if the cycles, as recommended by the CDC and WHO, are set too high resulting in false readings. The PCR test method has NEVER been proven it can specifically identify Covid-19. Just like the gene therapy technologies (pretend vaccines), PCR testing if for emergency use and has not gone through rigorous trials. And second, just what constitutes depression and how is it measured? Is it temporary or lasting? Could it be from some other pre-existing issues and like almost everything else, if you have a sniffle you are diagnosed with Covid? If you have a few bad days, you are automatically considered in a state of depression? Granted, many thousands have experienced severe depression over the last year, but those people are not considered as being in as much danger as a Covid patient. Hmm.

Comments are closed.